Skip to main content

Montreal Canadiens' Andrei Markov (79) celebrates his goal with teammate Max Pacioretty (67) over the Florida Panthers during first period NHL action in Montreal, January 22, 2013.

CHRISTINNE MUSCHI/REUTERS

And it was all going so well, Habs Nation.

Two victories in the team's first three games, with the wins coming through assured, balanced performances, with everyone healthy.

Now the Canadiens go into a rare Sunday evening game (6 p.m., RDS) against the Stanley Cup-finalist New Jersey Devils without their biggest offensive threat and with a possible hole on their blue line.

Story continues below advertisement

Winger Max Pacioretty, the Habs' leading scorer last year, had emergency surgery to remove an inflamed appendix on Saturday night, and will miss three or four weeks of action.

Defenceman Tomas Kaberle took a puck in the face in practice on Saturday, he's expected to be a game-time decision.

The Devils, meanwhile, roll into town as winners of their first three games.

A win would give them their first 4-0 start since 1995-96.

As ever, New Jersey is led by 40-year-old goalie Martin Brodeur, a Montreal native, who always seems to pull out great performances in his home town.

Brodeur has yielded just three goals through his first three starts, posting a save percentage of .958.

Montreal's Carey Price is only fractionally behind him at .953, and has given up only one even-strength goal to this point in the season, in garbage time during a comfortable 4-1 victory in Washington on Thursday.

Story continues below advertisement

Another player with Montreal ties will be making his Bell Centre debut. Rookie winger Stefan Matteau, who played the first part of the season with Blainville-Boisbriand of the QMJHL, is the son of former New York Ranger Stéphane.

The 2012 first-rounder – picked 25 slots after the Canadiens'18-year-old phenom Alex Galchenyuk– may even get to make his Montreal bow on the top line with Ilya Kovalchuk and Travis Zajac.

Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter